NanoCarrier Overview

  • Founded
  • 1996
Founded
  • Status
  • Public
  • Employees
  • 27
Employees
  • Stock Symbol
  • 4571
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $2.55
  • (As of Friday Closing)

NanoCarrier General Information

Description

NanoCarrier Co Ltd is engaged in the research and development of pharmaceuticals using micellar nanoparticles technology.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
TKS
Primary Office
  • 226-39 Wakashiba, Chiba
  • 15 Central 144 Blocks 15
  • Kashiwa-shi, 277-0871
  • Japan
+81 00-0000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NanoCarrier Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.55 $2.57 $2.30 - $3.77 $180M 70M 1.05M -$0.23

NanoCarrier Financials Summary

In Thousands,
USD
TTM 30-Sep-2021 FY 2021 31-Mar-2021 FY 2020 31-Mar-2020 FY 2019 31-Mar-2019
EV 136,489 129,003 73,410 147,819
Revenue 2,366 2,954 5,086 4,480
EBITDA (16,126) (26,823) (18,596) (16,350)
Net Income (16,083) (26,743) (18,483) (16,312)
Total Assets 73,226 70,896 82,764 77,275
Total Debt 10,273 0 0 22,322
Public Fundamental Data provided by Morningstar, Inc. disclaimer

NanoCarrier Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NanoCarrier‘s full profile, request access.

Request a free trial

NanoCarrier Patents

NanoCarrier Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-WO2017022665-A1 Polyion complex capable of efficiently delivering mrna into living body, and therapeutic agent and therapeutic method for arthropathy using the same Granted 31-Jul-2015 00000000000
JP-6812346-B2 Polyion complex that can efficiently deliver mrna into the living body, and therapeutic agents and treatment methods for arthropathy using this Active 31-Jul-2015 00000000000
US-20190008980-A1 Polyion complex capable of efficiently delivering mrna into living body, and drug and method for treating arthropathy in which said complex is used Abandoned 31-Jul-2015 00000000000
EP-3329925-B1 Polyion complex capable of delivering mrna into living body for treating arthropathy Active 31-Jul-2015 00000000000
EP-3329925-A1 Polyion complex capable of efficiently delivering mrna into living body, and drug and method for treating arthropathy in which said complex is used Granted 31-Jul-2015 A61K47/6455

NanoCarrier Executive Team (5)

Name Title Board Seat Contact Info
Tetsuhito Matsuyama President & Chief Executive Officer
Hiroyuki Hanada Chief Operating Officer & Board Member
You’re viewing 2 of 5 executive team members. Get the full list »

NanoCarrier Board Members (2)

Name Representing Role Since
Hiroyuki Hanada NanoCarrier Chief Operating Officer & Board Member 000 0000
You’re viewing 1 of 2 board members. Get the full list »

NanoCarrier Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NanoCarrier Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore NanoCarrier‘s full profile, request access.

Request a free trial

NanoCarrier Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 30-Sep-2020 0000000000 000.00 Drug Delivery
0000000 17-Jan-2017 00000 0000 00.000 Drug Delivery
AccuRna 16-Mar-2016 Seed Round Drug Delivery
To view NanoCarrier’s complete investments and acquisitions history, request access »

NanoCarrier Subsidiaries (1)

Company Name Industry Location Founded
0000000 Drug Delivery Bunkyo-ku, Japan 0000
To view NanoCarrier’s complete subsidiaries history, request access »